| abstract |
Compositions containing compounds with adrenergic activity and an extract of Crataegus standardized, or not, in flavonoids, combined with an extract of Gingko biloba standardized, or not, in flavonglucosides in appropriate weight ratios are suitable for pharmaceutical administration or as food supplements for the treatment of overweight and obesity in humans, in formulations appropriate for the administration of the active ingredients in a form that increases the patient's compliance and the efficacy of the therapeutic or dietary intervention, but reduces the untoward effects of the compounds with adrenergic activity. |